Paper · 42908026

Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer.

Tsai TF and 11 others. Cancer Cell Int, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer. Papers, record 42908026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908026

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer.
Journal: Cancer Cell Int
Year: 2026
Publication types: Journal Article
PubMed: https://pubmed.ncbi.nlm.nih.gov/42908026/
DOI: https://doi.org/10.1186/s12935-026-04397-x
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13685141/
The journal: https://conductscience.org/library/journal-index/101139795
Revised in PubMed: 2026-10-24

Source PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Tsai TF	Te-Fu
2	Chang HC	Hao-Chiun
3	Lin YY	Yen-You
4	Chen YC	Yen-Chen
5	Deng WP	Win-Ping
6	Hwang TI	Thomas I-Sheng
7	Chou KY	Kuang-Yu
8	Ho CY	Chao-Yen
9	Chen HE	Hung-En
10	Tang CH	Chih-Hsin

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Stated by
NSTC-110-2314-B-341-004	National Science and Technology Council	PubMed
NSTC-111-2314-B-341-004	National Science and Technology Council	PubMed
NSTC-110-2314-B-341-001-MY2	National Science and Technology Council	PubMed
2022SKHBDR001	Shin Kong Wu Ho-Su Memorial Hospital	PubMed
TMU113-AE1-B37	Taipei Medical University	PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References84

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	35,997,906	Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study.	Int Urol Nephrol	2022	https://conductscience.org/library/papers/35997906	PubMed
2	23,737,352	Recurrence of high-risk bladder cancer: a population-based analysis.	Cancer	2013	https://conductscience.org/library/papers/23737352	PubMed
3	15,102,692	Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.	Clin Cancer Res	2004	https://conductscience.org/library/papers/15102692	PubMed
4	33,419,373	The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.	Int J Mol Sci	2020	https://conductscience.org/library/papers/33419373	PubMed
5	11,740,820	Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.	Semin Oncol	2001	https://conductscience.org/library/papers/11740820	PubMed
6	31,014,516	Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer.	Crit Rev Oncol Hematol	2019	https://conductscience.org/library/papers/31014516	PubMed
7	37,316,561	Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer.	Sci Rep	2023	https://conductscience.org/library/papers/37316561	PubMed
8	27,473,037	Mitogen-Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation-Induced Cardiac Hypertrophy.	J Am Heart Assoc	2016	https://conductscience.org/library/papers/27473037	PubMed
9	27,367,653	Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses.	Molecules	2016	https://conductscience.org/library/papers/27367653	PubMed
10	19,038,771	Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.	J Pain	2008	https://conductscience.org/library/papers/19038771	PubMed

1 to 10 of 84

See all 84 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42908026

GET https://conductscience.org/api/papers/v1/42908026/references?page=2

API reference For AI assistants